What's Wrong With PepsiCo Stock?

PepsiCo shares are down 12% over five years and approximately 4% year-to-date in 2026, versus a roughly 70% five-year gain for the S&P 500 and a 55% gain for Coca-Cola. The article argues that concerns over GLP-1 drugs reducing snack demand may be excessively depressing PepsiCo's valuation, as the company continues to generate nearly $100 billion in annual revenue with sound profitability. At 18x earnings, PepsiCo trades below Coca-Cola's 27x multiple and the S&P 500's 24x average, supporting a contrarian value thesis.

Analysis

PEP's discount to KO is not simply a GLP-1 wager: it reflects a lower-quality earnings mix, with snacks carrying greater volume elasticity and more commodity/packaging exposure than KO's concentrate model. A reversal requires evidence that PEP can hold North America Frito-Lay volume while restoring price/mix without incremental trade spending; absent that, the lower multiple is justified by structurally weaker margin conversion rather than temporary sentiment.

The near-term setup is modestly favorable because GLP-1 penetration is still too low to explain a broad, sustained decline in packaged-snack consumption, and PEP has multiple mitigation levers—smaller pack sizes, permissible-indulgence innovation, protein/fiber extensions, and distribution scale. The more relevant 6-18 month risk is that retailers use weak category velocity to demand promotions, creating a volume-versus-margin tradeoff; this would pressure both PEP and suppliers such as MDLZ, though PEP's broad route-to-market makes its absolute exposure larger.

Consensus may be over-attributing PEP's underperformance to GLP-1 while underestimating the value of a stable dividend/FCF compounder if real rates fall. But the valuation gap should not mechanically close to KO's premium: KO's asset-light system and international beverage exposure warrant a persistent multiple advantage. The actionable catalyst is not a generic "cheap" narrative, but two consecutive quarters of volume stabilization and confirmation that gross-margin recovery is not being ceded back through promotional spend.

Key Decisions for Investors

• Initiate a 6-12 month long PEP / short KO pair at roughly beta-neutral sizing; target a 10-15% narrowing of the relative valuation gap if PEP delivers two quarters of stable North America snack volumes. Exit if PEP organic volume deteriorates by more than 2% for two consecutive quarters or management cuts margin guidance.
• For directional exposure, accumulate PEP only into post-earnings weakness if the selloff follows volume concerns without a reduction in full-year EPS or free-cash-flow guidance; initial upside is 12-18% including dividend over 12 months versus 8-10% downside if promotions accelerate.
• Do not use NFLX, NVDA, or GETY as read-through trades; their appearance is promotional and provides no investable linkage to PEP fundamentals.
• Set an alert around GLP-1 adoption data and PEP's Frito-Lay retail scanner trends: a material acceleration in persistent snack-category volume declines, rather than anecdotal appetite-suppression claims, would invalidate the long thesis and favor maintaining KO over PEP.